What are the payment terms?

We accept T/T, LC, PayPal, and Western Union for payment.

What is the lead time for production?

Lead time varies by season: within 15 workdays during off-season, and 1-3 months during peak season.

Similasan Manufacturing Line for Pharma Grade

Name: Similasan Manufacturing Line for Pharma Grade
Brand: Shanghai Pharmaceutical Machinery Co., Ltd.
SKU: 765812555

Shanghai, ChinaShanghai Pharmaceutical Machinery Co., Ltd.

Negotiable

1 Piece

Product profile

Certification

CE, GMP, ISO

Customized

5800-6000 Bottles Per Hour

Model NO.

DSG2/80

Type

Pharmaceutical Packaging Machinery

Finished Dosage Form

Liquid

Precision

High Precision

Voltage

380V

Computerized

Condition

New

Warranty

1 Year

Transport Package

Plywooden Case

Specification

Trademark

SPM

Origin

China

HS Code

84224000

Production Capacity

10000 Per Year

Key features

High Production Capacity: Produces 5800-6000 bottles per hour, suitable for high-capacity eye drop manufacturing.

GMP Compliant Design: Integrated GMP requirements ensure contamination-free and easy-to-clean machinery.

Precise Filling Performance: Peristaltic pump ensures no dripping, no forming, and no spitting with high precision.

Flexible Customization: Supports customization from samples, designs, and minor adjustments for various specs.

Stainless Steel Construction: Outer material is dull polished stainless steel; contact parts use SS316L or PTFE.

Versatile Control System: Allows single machine control or interlock control for flexible operation management.

1-Year Warranty Coverage: Comprehensive 1-year warranty provided for all mechanical equipment defects.

Company profile

Experienced TeamExhibition ExperienceImporters and ExportersLow MOQ

Shanghai Pharmaceutical Machinery Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤6.28h CertifiedTerms of Payment: T/T, LC, PayPal, etc.

AI-Powered supplier vetting

SummaryThe supplier is identified as a Shanghai-based combined trading company with listed pharmaceutical equipment products and machining-related facilities. It reports extensive customization, R&D activity with new products in the past year, export experience of 20 years, and exports representing 90% of total sales. After-sales support includes repair services and overseas agents or branches, but no overseas warehouse or showroom. Finished-product inspection instructions are reportedly available and uniformly followed. The supplier does not provide ODM services, lacks an available SDK, and does not provide OEM services for well-known brands. Evidence is insufficient to verify certifications, detailed financial credibility, production scale, or named customer cases.

After-Sales capabilityThe supplier reports repair as an overseas service offering and states that it can provide services through overseas agents or branches. However, it has no overseas warehouse or showroom, so the evidence supports some service access but not comprehensive overseas infrastructure.

R&D capabilityThe supplier reports R&D capability and states that it launched new products during the past year. It does not have an available SDK and does not provide ODM services, but these limitations do not negate the explicit evidence of recent product development.

Production capacityThe supplier lists machining centers, CNC and milling equipment, provides a broad pharmaceutical-equipment product range, and reports a finished-product inspection method with instructions that are uniformly followed. However, the supplied data does not quantify production capacity, output, or manufacturing ownership, so production strength is only partially evidenced.

Customization capabilityBoth R&D and design-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization offering.